MARC

LEADER 00000nab a2200000uu 4500
001 3265313103
003 UK-CbPIL
022 |a 1101-1262 
022 |a 1464-360X 
024 7 |a 10.1093/eurpub/ckaf161.1714  |2 doi 
035 |a 3265313103 
045 2 |b d20251001  |b d20251031 
084 |a 53202  |2 nlm 
100 1 |a Torres Blanco, V A  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico 
245 1 |a Health inequities in adolescents with Down syndrome: overlooked risk of type 2 diabetes mellitus 
260 |b Oxford University Press  |c Oct 2025 
513 |a General Information 
520 3 |a Background Down syndrome (DS), the most common aneuploidy worldwide, is associated with metabolic anomalies affecting insulin and glucose regulation, increasing the risk of type 2 diabetes mellitus (T2DM). Despite this, adolescents with DS are often excluded from public health strategies, especially in low-resource settings where early screening and tailored interventions are limited. This study explores the association between DS and T2DM risk in adolescents in Veracruz, México, and highlights the urgent need to adapt inclusive prevention frameworks in public health systems. Methods A cross-sectional, prospective study was conducted in Veracruz, México; between September and December 2024, including adolescents aged 12-18. Those with diabetes or using medications that alter glucose or insulin metabolism were excluded. DS was the main independent variable. Dependent variables included T2DM risk, acanthosis nigricans (AN), high BMI, abdominal obesity, low physical activity, and poor diet, assessed via FINDRISC-A, PAQ-A and KIDMED (Cronbach's alpha: 0.84, 0.67, 0.79, respectively). Non-probability sampling was used. After ethics approval, informed consent was obtained from parents and adolescents. Data were analyzed using SPSS v.27. Results 122 adolescents were included, 21 (17.2%) had DS. Overall, 25 participants (36.3%) had moderate to high T2DM risk. DS was significantly associated with elevated T2DM risk (OR: 5.91; 95% CI: 2.09-16.71; p < 0.001), AN (OR: 19.8; 95% CI: 3.65-107.3; p < 0.001), and abdominal obesity (OR: 3.17; 95% CI: 1.17-8.57; p = 0.01). No significant associations were found with physical activity or diet (p > 0.05). Conclusions Adolescents with DS show a clear metabolic vulnerability, underscoring the need for inclusive screening and early prevention. Public health systems must adapt to address atypical risk profiles and reduce health inequities for youth with disabilities. Key messages • Early detection of metabolic risk in adolescents with Down syndrome is crucial to prevent the early onset of type 2 diabetes and reduce long-term health disparities. • Public health strategies must recognize Down syndrome as a metabolic risk group and implement inclusive, community-based screening and prevention programs. 
653 |a Physical fitness 
653 |a Insulin 
653 |a Exercise 
653 |a Physical activity 
653 |a Adolescents 
653 |a Diabetes 
653 |a Health disparities 
653 |a Metabolism 
653 |a Down syndrome 
653 |a Risk 
653 |a Dependent variables 
653 |a Glucose 
653 |a Prenatal diagnosis 
653 |a Acanthosis nigricans 
653 |a Informed consent 
653 |a Obesity 
653 |a Public health 
653 |a Variables 
653 |a Screening 
653 |a Teenagers 
653 |a Diet 
653 |a Diabetes mellitus (non-insulin dependent) 
653 |a Glucose metabolism 
653 |a Aneuploidy 
653 |a Independent variables 
653 |a Prevention 
653 |a Longitudinal studies 
653 |a Down's syndrome 
653 |a Sampling 
653 |a Diabetes mellitus 
653 |a Risk reduction 
653 |a Health planning 
653 |a Ethics 
653 |a Age of onset 
653 |a Inequality 
653 |a Tests 
653 |a Health education 
653 |a Community-based programs 
653 |a Community organizations 
653 |a Prevention programs 
653 |a Health services 
653 |a Type 2 diabetes mellitus 
653 |a Body weight 
653 |a Medical screening 
653 |a Body mass index 
653 |a Social 
700 1 |a Hernández Cervantes, A E  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico 
700 1 |a Ceballos Vela, M C  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico 
700 1 |a Villegas Domínguez, J E  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico 
700 1 |a Ceballos Carrasco, A A  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico 
700 1 |a Hernández Sánchez, G  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico 
700 1 |a Cruz Estudillo, A C  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico 
700 1 |a Zarate Martinez, G  |u Facultad de Medicina, Región Veracruz, Universidad Veracruzana, Veracruz, Mexico; zS20011325@estudiantes.uv.mx 
773 0 |t European Journal of Public Health  |g vol. 35, no. Supplement_4 (Oct 2025) 
786 0 |d ProQuest  |t ABI/INFORM Global 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3265313103/abstract/embedded/BH75TPHOCCPB476R?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3265313103/fulltextPDF/embedded/BH75TPHOCCPB476R?source=fedsrch